amifostine anhydrous has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, SH; He, M; Li, J; Liu, T; Wu, DM; Xu, Y; Yu, Y; Zhang, T; Zhao, YY | 1 |
1 other study(ies) available for amifostine anhydrous and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway.
Topics: Amifostine; Animals; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Mice; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Radiation-Protective Agents; Reactive Oxygen Species | 2020 |